SUSQUEHANNA INTERNATIONAL GROUP, LLP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$1,824,145
-54.4%
117,915
-53.7%
0.00%
-100.0%
Q2 2023$3,998,195
+250.8%
254,500
+267.9%
0.00%
Q1 2023$1,139,889
-94.0%
69,168
-94.3%
0.00%
-100.0%
Q4 2022$18,887,217
+576.0%
1,210,719
+462.0%
0.00%
Q3 2022$2,794,000
-88.3%
215,425
-87.4%
0.00%
-100.0%
Q2 2022$23,942,000
-3.5%
1,705,242
-1.6%
0.01%
+50.0%
Q1 2022$24,820,000
-36.7%
1,733,220
-39.7%
0.00%
+300.0%
Q4 2021$39,200,000
-5.0%
2,875,930
+14.2%
0.00%
-80.0%
Q3 2021$41,257,000
-9.0%
2,518,708
-6.5%
0.01%
-16.7%
Q2 2021$45,338,000
-44.7%
2,693,858
-40.0%
0.01%
-50.0%
Q1 2021$82,039,000
-13.7%
4,492,885
-14.0%
0.01%
+50.0%
Q4 2020$95,028,000
+259.3%
5,221,374
+252.2%
0.01%
+60.0%
Q3 2020$26,449,000
+3.3%
1,482,637
+3.8%
0.01%
-28.6%
Q2 2020$25,599,000
-2.6%
1,427,687
-17.5%
0.01%
-12.5%
Q1 2020$26,284,000
-27.2%
1,731,454
-5.3%
0.01%
-20.0%
Q4 2019$36,086,000
+9.6%
1,829,028
-4.4%
0.01%
-9.1%
Q3 2019$32,919,000
-65.3%
1,913,938
-64.3%
0.01%
-8.3%
Q2 2019$94,801,000
+187.5%
5,355,922
+230.9%
0.01%
-14.3%
Q1 2019$32,974,000
+1003.9%
1,618,800
+811.5%
0.01%
+1300.0%
Q4 2018$2,987,000177,6000.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2023
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders